» Articles » PMID: 28876402

Analysis of Biofilm Production by Clinical Isolates of Pseudomonas Aeruginosa from Patients with Ventilator-associated Pneumonia

Overview
Date 2017 Sep 7
PMID 28876402
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To phenotypically evaluate biofilm production by Pseudomonas aeruginosa clinically isolated from patients with ventilator-associated pneumonia.

Methods: Twenty clinical isolates of P. aeruginosa were analyzed, 19 of which were from clinical samples of tracheal aspirate, and one was from a bronchoalveolar lavage sample. The evaluation of the capacity of P. aeruginosa to produce biofilm was verified using two techniques, one qualitative and the other quantitative.

Results: The qualitative technique showed that only 15% of the isolates were considered biofilm producers, while the quantitative technique showed that 75% of the isolates were biofilm producers. The biofilm isolates presented the following susceptibility profile: 53.3% were multidrug-resistant, and 46.7% were multidrug-sensitive.

Conclusion: The quantitative technique was more effective than the qualitative technique for the detection of biofilm production. For the bacterial population analyzed, biofilm production was independent of the susceptibility profile of the bacteria, demonstrating that the therapeutic failure could be related to biofilm production, as it prevented the destruction of the bacteria present in this structure, causing complications of pneumonia associated with mechanical ventilation, including extrapulmonary infections, and making it difficult to treat the infection.

Citing Articles

Vitamin D and vitamin K1 as novel inhibitors of biofilm in Gram-negative bacteria.

Lutfi L, Shaaban M, Elshaer S BMC Microbiol. 2024; 24(1):173.

PMID: 38762474 PMC: 11102130. DOI: 10.1186/s12866-024-03293-6.


Olive oil nanoemulsion containing curcumin: antimicrobial agent against multidrug-resistant bacteria.

Confessor M, Agreles M, Almeida Campos L, Neto A, Borges J, Martins R Appl Microbiol Biotechnol. 2024; 108(1):241.

PMID: 38413482 PMC: 10899360. DOI: 10.1007/s00253-024-13057-x.


Prevalence of Type III Secretion System (T3SS) and Biofilm Development in Genetically Heterogeneous Clinical Isolates of Pseudomonas aeruginosa from Nigeria.

Olaniran O, Donia A, Adeleke O, Bokhari H Curr Microbiol. 2023; 80(11):349.

PMID: 37733140 DOI: 10.1007/s00284-023-03467-x.


Assessment of biofilms formation of bacterial and fungal isolates using qualitative Congo red agar and semiquantitative crystal violet microtiter methods.

Moreno X, Ventura M, Panizo M, Garces M Biomedica. 2023; 43(Sp. 1):77-88.

PMID: 37721922 PMC: 10574781. DOI: 10.7705/biomedica.6732.


Antimicrobial Resistance, Genetic Lineages, and Biofilm Formation in Isolated from Human Infections: An Emerging One Health Concern.

Silva A, Silva V, Lopez M, Rojo-Bezares B, Carvalho J, Castro A Antibiotics (Basel). 2023; 12(8).

PMID: 37627668 PMC: 10451160. DOI: 10.3390/antibiotics12081248.


References
1.
Furtado G, Bergamasco M, Menezes F, Marques D, Silva A, Perdiz L . Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality. J Crit Care. 2009; 24(4):625.e9-14. DOI: 10.1016/j.jcrc.2009.03.006. View

2.
Friedman L, Kolter R . Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol Microbiol. 2004; 51(3):675-90. DOI: 10.1046/j.1365-2958.2003.03877.x. View

3.
Santos P, Mariano M, Kallas M, Vilela M . Impact of tongue biofilm removal on mechanically ventilated patients. Rev Bras Ter Intensiva. 2013; 25(1):44-8. PMC: 4031859. DOI: 10.1590/s0103-507x2013000100009. View

4.
Sousa A, Pereira M . Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. Pathogens. 2014; 3(3):680-703. PMC: 4243435. DOI: 10.3390/pathogens3030680. View

5.
Parker C, Kutsogiannis J, Muscedere J, Cook D, Dodek P, Day A . Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care. 2008; 23(1):18-26. DOI: 10.1016/j.jcrc.2008.02.001. View